Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2021 Aug 4;156(3):399-408.
doi: 10.1093/ajcp/aqaa238.

Spectrum of Kidney Diseases in Patients With Hepatitis C Virus Infection

Affiliations
Comparative Study

Spectrum of Kidney Diseases in Patients With Hepatitis C Virus Infection

Shunhua Guo et al. Am J Clin Pathol. .

Abstract

Objectives: To study the pathologic spectrum of kidney diseases in patients with hepatitis C virus infection (HCV+).

Methods: Native kidney biopsy specimens in HCV+ patients were reviewed.

Results: A total of 9,836 native kidney biopsy specimens were evaluated from January 2007 to December 2016, of which 273 (2.8%) were from HCV+ patients, and of these, 115 (42.1%) had diagnoses consistent with HCV-associated glomerulonephritis (GN). Non-HCV-associated kidney diseases comprised most diagnoses (158 cases, 57.9%) including non-immune complex-mediated kidney diseases (127 cases, 46.5%) and other immune complex-mediated glomerular diseases (31 cases, 11.4%). Forty-one (40.6%) patients had HCV-associated GN among 101 HCV+ patients from 2007 to 2011 vs 74 (43.0%) patients with HCV-associated GN among 172 HCV+ patients from 2012 to 2016. HCV-associated GN showed five morphologic patterns: focal proliferative (5.2%), diffuse mesangial proliferative (50.4%), diffuse membranoproliferative (28.7%), proliferative GN with crescentic lesions (7.8%), and membranous patterns (7.8%).

Conclusions: We found a spectrum of pathologic changes in renal biopsy specimens of HCV+ patients, with most having diseases unrelated to HCV infection, HCV-associated GN showing five morphologic patterns, and availability of effective HCV antiviral therapy not yet resulting in major changes in the spectrum of kidney diseases in these patients.

Keywords: Cryoglobulinemia; HCV-associated glomerulonephritis; Hepatitis C virus (HCV); Kidney disease.

PubMed Disclaimer

Figures

Image 1
Image 1
Pathologic features of hepatitis C virus (HCV)–associated glomerulonephritis. A, The classic kidney injury typically seen in HCV-associated glomerulonephritis is characterized by mesangial and endocapillary hypercellularity and double contours of the glomerular basement membrane (Jones’s silver, ×200). B, Cryoglobulin deposition can be demonstrated as periodic acid–Schiff stain-positive intraluminal cryo plugs, also called hyaline pseudothrombi in glomerular capillary lumens (×200). C-E, Immunofluorescence shows deposits with often immunoglobulin M dominance (C, ×200) and skewed light chain deposition (one light chain stronger than the other): κ light chain (D, ×200) and λ light chain (E, ×200). F, Electron microscopy shows subendothelial and mesangial deposits and intraluminal cryo plug with short fibrillary substructure (×8,900).
Image 1
Image 1
Pathologic features of hepatitis C virus (HCV)–associated glomerulonephritis. A, The classic kidney injury typically seen in HCV-associated glomerulonephritis is characterized by mesangial and endocapillary hypercellularity and double contours of the glomerular basement membrane (Jones’s silver, ×200). B, Cryoglobulin deposition can be demonstrated as periodic acid–Schiff stain-positive intraluminal cryo plugs, also called hyaline pseudothrombi in glomerular capillary lumens (×200). C-E, Immunofluorescence shows deposits with often immunoglobulin M dominance (C, ×200) and skewed light chain deposition (one light chain stronger than the other): κ light chain (D, ×200) and λ light chain (E, ×200). F, Electron microscopy shows subendothelial and mesangial deposits and intraluminal cryo plug with short fibrillary substructure (×8,900).

References

    1. Mohd Hanafiah K, Groeger J, Flaxman AD, et al. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013;57:1333-1342. - PubMed
    1. Morales JM, Kamar N, Rostaing L. Hepatitis C and renal disease: epidemiology, diagnosis, pathogenesis and therapy. Contrib Nephrol. 2012;176:10-23. - PubMed
    1. El-Serag HB, Hampel H, Yeh C, et al. Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology. 2002;36:1439-1445. - PubMed
    1. Pascual M, Perrin L, Giostra E, et al. Hepatitis C virus in patients with cryoglobulinemia type II. J Infect Dis. 1990;162:569-570. - PubMed
    1. Johnson RJ, Gretch DR, Yamabe H, et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med. 1993;328:465-470. - PubMed

Publication types